McKesson (MCK) Stock Price, News & Analysis

Company Overview

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support. Its products and services help customers manage medication procurement, inventory, dispensing and clinical workflows. Through its specialty operations, McKesson supports the distribution and administration of complex therapies, including treatments used in oncology and other areas of specialty medicine.

Founded in 1833 by John McKesson and Charles Olcott, the company has grown through expansion and acquisitions into a major healthcare services organization. McKesson primarily serves customers in the United States and Canada, with operations and capabilities spanning community pharmacies, hospitals, health systems, manufacturers and specialty care providers. The company is headquartered in Irving, Texas.

Key Stats

• Today's Range: $1,005.42 to $1,030.00
• 50-Day Range: $841.21 to $1,029.52
• 52-Week Range: $723.68 to $1,030.27
• Volume: 772,054 shs
• Average Volume: 928,098 shs
• Market Capitalization: $118.31 billion
• P/E Ratio: 27.16
• Dividend Yield: 0.37%
• Price Target: $997.12
• Consensus Rating: Moderate Buy

McKesson Stock Analysis - MarketRank™

McKesson scored higher than 92% of companies evaluated by MarketBeat, and ranked 27th out of 902 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

McKesson has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on no strong buy ratings, 15 buy ratings, 4 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for McKesson is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

McKesson has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 11.81%

Earnings Growth

Earnings for McKesson are expected to grow by 11.81% in the coming year, from $44.71 to $49.99 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of McKesson is 27.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.85.

Price to Earnings Ratio vs. Sector

The P/E ratio of McKesson is 27.16, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.32.

Price to Earnings Growth Ratio

McKesson has a PEG Ratio of 2.01. PEG Ratios above 1 indicate that a company could be overvalued.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.96% of the float of McKesson has been sold short.

Short Interest Ratio / Days to Cover

McKesson has a short interest ratio ("days to cover") of 2.65, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in McKesson has recently decreased by 21.20%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

McKesson has a dividend yield of 0.37%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

McKesson has been increasing its dividend for 17 years.

Dividend Coverage

The dividend payout ratio of McKesson is 10.06%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, McKesson will have a dividend payout ratio of 7.52% next year. This indicates that McKesson will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.2 / 5
• News Sentiment: 0.78

News Sentiment

McKesson has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 40 news articles for McKesson this week, compared to 7 articles on an average week.

Search Interest

12 people have searched for MCK on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.

MarketBeat Follows

11 people have added McKesson to their MarketBeat watchlist in the last 30 days. This is an increase of 267% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, McKesson insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,164,182.00 in company stock.

Percentage Held by Insiders

0.06% of the stock of McKesson is held by insiders.

Percentage Held by Institutions

85.07% of the stock of McKesson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Record date for 10/1 Dividend: 9/01/2026
• Ex-Dividend for 10/1 Dividend: 9/01/2026
• Dividend Payable: 10/01/2026
• Today: 10/21/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Distributors
• Current Symbol: NYSE:MCK
• CIK: 927653
• Web: www.mckesson.com
• Phone: (972) 446-4800
• Fax: 415-983-8453
• Employees: 43,000
• Year Founded: 1833

Price Target and Rating

• Average Price Target for McKesson: $997.12
• High Price Target: $1,200.00
• Low Price Target: $845.00
• Potential Upside/Downside: -1.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.79
• Research Coverage: 19 Analysts

Profitability

• EPS (Trailing Twelve Months): $37.37
• Trailing P/E Ratio: 27.16
• Forward P/E Ratio: 22.70
• P/E Growth: 2.01
• Net Income: $4.76 billion
• Net Margins: 1.12%
• Pretax Margin: 1.57%
• Return on Equity: -253.21%
• Return on Assets: 5.90%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.89
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $410.98 billion
• Price / Sales: 0.29
• Cash Flow: $45.77 per share
• Price / Cash Flow: 22.17
• Book Value: ($14.51) per share
• Price / Book: -69.94

Miscellaneous

• Outstanding Shares: 116,590,000
• Free Float: 116,520,000
• Market Cap: $118.31 billion
• Optionable: Optionable
• Beta: 0.30